Collectively, the 30 Sensex companies are estimated to have spent about Rs 3,500 crore on CSR initiatives during the 2014-15 fiscal, when they were required to spend nearly Rs 5,000 crore on such activities under the new Companies Act.
Together, they are estimated to have clocked a three-year-average net profit of Rs 2.5 lakh crore, of which they were required to spend 2% on Corporate Social Responsibility (CSR).
Making the scorecard even worse, just seven of them could meet this two% threshold in time. These firms include Mukesh Ambani-led Reliance Industries, ITC, Mahindra and Mahindra, Wipro, Hindustan Unilever, Tata Steel and Coal India, while Infosys also managed to meet the target although after a delay by a few days for a small amount of Rs 3 crore.
Interestingly, quite a few companies have also tried to defend their failure to meet the threshold with reasons like 'money already having been earmarked' and 'delays in getting requisite approvals for spending the prescribed amounts'.
The companies whose actual CSR spending was less than 2% during the year included HDFC Bank, ICICI Bank, Axis Bank, SBI, Dr Reddy's, HDFC, Bajaj Auto, Bharti Airtel, Hero Motocorp, Hindalco, Larsen and Toubro, TCS, Lupin, Cipla, Maruti Suzuki, GAIL, NTPC, BHEL and ONGC.
All of them have expressed commitment to the CSR work.
Corporate giant Reliance Industries Ltd (RIL) spent the the maximum amount (Rs 761 crore) among the Sensex companies on CSR during 2014-15 - the first financial year for which the new law has been in force.
RIL is followed by ONGC in terms of absolute amount at Rs 495 crore, although it could spend only 1.5% of its three-year-average net profit.
There is no penalty as such for missing this threshold, but the company needs to explain the reasons for its failure to spend at least 2% on CSR. The government has set up a six-member panel to suggest steps for improved monitoring of social welfare activities done under the Companies Act.
At least two companies, Vedanta Ltd and Tata Motors, did not have any obligation to meet the CSR threshold as they did not meet the requirement due to losses. The exact figures for Sun Pharma could not be ascertained.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)